Display options
Share it on
Full text links
Springer

Arch Toxicol. 1980 Jul;45(2):81-92. doi: 10.1007/BF01270905.

Toxicokinetic and toxicodynamic studies of beryllium.

Archives of toxicology

T Stiefel, K Schulze, H Zorn, G Tölg

PMID: 6162434 DOI: 10.1007/BF01270905

Abstract

The question of dose-effect relations of berylliosis was examined by measuring the Be-concentration in blood and urine, as well as the immunological behaviour of T-lymphocytes for a group of occupationally exposed men (smaller than 8 ng Be/m3, 4-6 h daily) and a non-exposed control group. Normal values 1.0 +/- 0.4 ng Be/g(n=10) in blood and 0.9 +/- 0.5 ng Be/g(n=10) in urine were found by an optimized flameless atomic absorption spectrometry method. The corresponding values for the exposed group (n=8) showed a mean increase of a factor of 4. The preferential enrichment of Be in the prealbumin and in the nu-globulin fractions was determined by a preparative isotachophoretic column with physiological pH conditions, especially developed for this application. The Be-specific stimulation of the T-lymphocytes of the exposed group was increased significantly. In blood and urine samples of exposed (2-40 mg Be/m3 as Be(NO3)2) Wistar-rats and guinea pigs Be values up to 36 ng Be/g in serum and up to 300 ng Be/g in urine were determined. After Be exposure, guinea pig serum showed a significant increase in the nu-globulins after the isotachophoretical separation of the serum proteins, which could not be correlated with increased Be-levels in this fraction. 70% of the total Be(10-100 ng/g serum) were detected in the prealbumin, only about 1% in the nu-globulin fraction. The same results were found in serum samples with in vitro addition of Be. The lymphocyte transformation rates for the exposed animals were increased. Skin tests were found to be positive in 70% for exposed rats and in 50-70% for guinea pigs.

Cited by

References

  1. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1969;263(1):277 - PubMed
  2. Chest. 1973 Mar;63(3):309-13 - PubMed
  3. J Occup Med. 1973 Mar;15(3):255-9 - PubMed
  4. J Allergy Clin Immunol. 1977 Jun;59(6):425-36 - PubMed
  5. Anal Chim Acta. 1976 Nov;87(1):67-78 - PubMed
  6. AMA Arch Derm Syphilol. 1951 Oct;64(4):470-82 - PubMed
  7. AMA Arch Ind Hyg Occup Med. 1951 Aug;4(2):123-51 - PubMed
  8. J Immunol. 1973 Aug;111(2):590-8 - PubMed
  9. Zentralbl Arbeitsmed Arbeitsschutz Prophyl. 1977 Apr;27(4):83-8 - PubMed
  10. Anal Biochem. 1966 Apr;15(1):45-52 - PubMed
  11. Biochem J. 1968 Feb;106(4):811-20 - PubMed
  12. Farmakol Toksikol. 1976 Sep-Oct;39(5):615-8 - PubMed
  13. Farmakol Toksikol. 1976 Jun-Aug;39(4):474-7 - PubMed
  14. AMRL TR. 1968 Dec;:1-236 - PubMed
  15. Proc Soc Exp Biol Med. 1952 Jan;79(1):97-9 - PubMed
  16. Gig Tr Prof Zabol. 1977 Oct;(10):52-4 - PubMed
  17. Arch Biochem Biophys. 1953 Oct;46(2):443-53 - PubMed
  18. J Soc Occup Med. 1977 Jul;27(3):93-6 - PubMed
  19. Am Ind Hyg Assoc J. 1972 Jan;33(1):45-52 - PubMed
  20. J Hyg Epidemiol Microbiol Immunol. 1977;21(3):254-60 - PubMed
  21. Gig Tr Prof Zabol. 1976 Aug;(8):19-22 - PubMed
  22. Bull Cancer. 1975 Jan-Mar;62(1):49-58 - PubMed

Substances

MeSH terms

Publication Types

LinkOut - more resources